Table 5. Open in new tab Data on missing...

	T0	T1	T2	T3
Patients	MFT
with	WSL(s) at T0	3.5	2.72	1.6–5.4	3.5	.085	5.1	3.27	2.4–7.9	4.5	.018	7.1	5.23	3.1–11.1	6.0	.008	10.4	6.1	6.3–14.5	11.0	.043
without	2.3	2.99	1.5-3.1	1.0	2.5	3.20	1.6-3.3	2.0	2.6	2.77	1.8-3.4	1.0	6.5	4.4	5.4-7.6	7.0
with	WSL(s) at T1	2.9	2.43	1.9–3.9	3.0	.064	3.9	2.77	2.6–5.1	3.0	.009	5.2	4.24	3.3–7.0	5.0	.003	9.5	5.2	7.5–11.6	9.0	.002
without	2.2	3.25	1.1–3.2	1.0	2.3	3.44	1.2-3.3	1.0	2.1	2.53	1.3–3.0	1.0	5.6	3.9	4.4–6.8	6.0
with	new or deteriorated WSL(s) at T1	3.0	2.49	1.9–4.1	3.0	.104	3.6	2.71	2.3–4.9	3.0	.052	5.2	4.45	3.1–7.4	5.0	.018	9.9	5.5	7.5–12.3	9.0	.003
without	2.2	3.16	1.2–3.1	1.0	2.5	3.48	1.4–3.5	1.0	2.4	2.73	1.5–3.3	1.0	5.8	4.0	4.7–6.9	6.5
MT
with	WSL(s) at T0	0.0	0.00	0.0–0.0	0.0	1.000	0.0	0.00	0.0–0.0	0.0	.593	0.0	0.00	0.0–0.0	0.0	.549	0.4	0.92	-0.3–1.0	0.0	.522
without	0.0	0.00	0.0–0.0	0.0	0.1	0.29	0.0–0.1	0.0	0.1	0.31	0.0–0.2	0.0	0.2	0.65	0.0–0.4	0.0
with	WSL(s) at T1	0.0	0.00	0.0–0.0	0.0	1.000	0.1	0.43	–0.1-0.3	0.0	.610	0.1	0.42	-0.1–0.3	0.0	.714	0.4	1.01	0.0–0.9	0.0	.049
without	0.0	0.00	0.0–0.0	0.0	0.0	0.15	0.0–0.1	0.0	0.0	0.16	0.0–0.1	0.0	0.1	0.36	0.0–0.2	0.0
with	new or deteriorated WSL(s) at T1	0.0	0.00	0.0–0.0	0.0	1.000	0.1	0.46	−0.1–0.3	0.0	.500	0.1	0.46	−0.1–0.3	0.0	.557	0.6	1.10	0.1–1.0	0.0	.011
without	0.0	0.00	0.0–0.0	0.0	0.0	0.15	0.0–0.7	0.0	0.0	0.16	0.0–0.1	0.0	0.1	0.34	0.0–0.2	0.0
FT
with	WSL(s) at T0	3.5	2.72	1.6–5.4	3.5	.085	5.1	3.27	2.4–7.9	4.5	.016	7.1	5.23	3.1–11.1	6.0	.008	10.0	5.60	6.2–13.8	11.0	.034
without	2.3	2.99	1.5–3.1	1.0	2.4	3.17	1.6–3.3	2.0	2.6	2.72	1.8–3.3	1.0	6.3	4.22	5.2–7,4	7.0
with	WSL(s) at T1	2.9	2.43	1.9–3.9	3.0	.064	3.8	2.69	2.6–5.0	3.0	.010	5.1	4.20	3.3–6.9	5.0	.003	9.1	4.95	7.1–11.0	8.0	.003
without	2.2	3.25	1.1–3.2	1.0	2.2	3.46	1.2–3.3	1.0	2.1	2.54	1.2–2.9	1.0	5.5	3.88	4.3–6.7	6.0
with	new or deteriorated WSL(s) at T1	3.0	2.49	1.9–4.1	3.0	.104	3.5	2.61	2.3–4.8	3.0	.054	5.1	4.41	3.0–7.2	5.0	.018	9.4	5.16	7.1–11.7	8.5	.005
without	2.2	3.16	1.2–3.1	1.0	2.4	3.49	1.4–3.5	1.0	2.4	2.75	1.5–3.2	1.0	5.7	3.92	4.6–6.9	6.0

95% CI

Med

95% CI

Med

95% CI

Med

95% CI

Med

Patients

MFT

with

WSL(s) at T0

3.5

2.72

1.6–5.4

3.5

.085

5.1

3.27

2.4–7.9

4.5

.018

7.1

5.23

3.1–11.1

6.0

.008

10.4

6.1

6.3–14.5

11.0

.043

without

2.3

2.99

1.5-3.1

1.0

2.5

3.20

1.6-3.3

2.0

2.6

2.77

1.8-3.4

1.0

6.5

4.4

5.4-7.6

7.0

with

WSL(s) at T1

2.9

2.43

1.9–3.9

3.0

.064

3.9

2.77

2.6–5.1

3.0

.009

5.2

4.24

3.3–7.0

5.0

.003

9.5

5.2

7.5–11.6

9.0

.002

without

2.2

3.25

1.1–3.2

1.0

2.3

3.44

1.2-3.3

1.0

2.1

2.53

1.3–3.0

1.0

5.6

3.9

4.4–6.8

6.0

with

new or deteriorated WSL(s) at T1

3.0

2.49

1.9–4.1

3.0

.104

3.6

2.71

2.3–4.9

3.0

.052

5.2

4.45

3.1–7.4

5.0

.018

9.9

5.5

7.5–12.3

9.0

.003

without

2.2

3.16

1.2–3.1

1.0

2.5

3.48

1.4–3.5

1.0

2.4

2.73

1.5–3.3

1.0

5.8

4.0

4.7–6.9

6.5

with

WSL(s) at T0

0.0

0.00

0.0–0.0

0.0

1.000

0.0

0.00

0.0–0.0

0.0

.593

0.0

0.00

0.0–0.0

0.0

.549

0.4

0.92

-0.3–1.0

0.0

.522

without

0.0

0.00

0.0–0.0

0.0

0.1

0.29

0.0–0.1

0.0

0.1

0.31

0.0–0.2

0.0

0.2

0.65

0.0–0.4

0.0

with

WSL(s) at T1

0.0

0.00

0.0–0.0

0.0

1.000

0.1

0.43

–0.1-0.3

0.0

.610

0.1

0.42

-0.1–0.3

0.0

.714

0.4

1.01

0.0–0.9

0.0

.049

without

0.0

0.00

0.0–0.0

0.0

0.15

0.0–0.1

0.0

0.16

0.0–0.1

0.0

0.1

0.36

0.0–0.2

0.0

with

new or deteriorated WSL(s) at T1

0.0

0.00

0.0–0.0

0.0

1.000

0.1

0.46

−0.1–0.3

0.0

.500

0.1

0.46

−0.1–0.3

0.0

.557

0.6

1.10

0.1–1.0

0.0

.011

without

0.0

0.00

0.0–0.0

0.0

0.15

0.0–0.7

0.0

0.16

0.0–0.1

0.0

0.1

0.34

0.0–0.2

0.0

with

WSL(s) at T0

3.5

2.72

1.6–5.4

3.5

.085

5.1

3.27

2.4–7.9

4.5

.016

7.1

5.23

3.1–11.1

6.0

.008

10.0

5.60

6.2–13.8

11.0

.034

without

2.3

2.99

1.5–3.1

1.0

2.4

3.17

1.6–3.3

2.0

2.6

2.72

1.8–3.3

1.0

6.3

4.22

5.2–7,4

7.0

with

WSL(s) at T1

2.9

2.43

1.9–3.9

3.0

.064

3.8

2.69

2.6–5.0

3.0

.010

5.1

4.20

3.3–6.9

5.0

.003

9.1

4.95

7.1–11.0

8.0

.003

without

2.2

3.25

1.1–3.2

1.0

2.2

3.46

1.2–3.3

1.0

2.1

2.54

1.2–2.9

1.0

5.5

3.88

4.3–6.7

6.0

with

new or deteriorated WSL(s) at T1

3.0

2.49

1.9–4.1

3.0

.104

3.5

2.61

2.3–4.8

3.0

.054

5.1

4.41

3.0–7.2

5.0

.018

9.4

5.16

7.1–11.7

8.5

.005

without

2.2

3.16

1.2–3.1

1.0

2.4

3.49

1.4–3.5

1.0

2.4

2.75

1.5–3.2

1.0

5.7

3.92

4.6–6.9

6.0

	T0	T1	T2	T3
Patients	MFT
with	WSL(s) at T0	3.5	2.72	1.6–5.4	3.5	.085	5.1	3.27	2.4–7.9	4.5	.018	7.1	5.23	3.1–11.1	6.0	.008	10.4	6.1	6.3–14.5	11.0	.043
without	2.3	2.99	1.5-3.1	1.0	2.5	3.20	1.6-3.3	2.0	2.6	2.77	1.8-3.4	1.0	6.5	4.4	5.4-7.6	7.0
with	WSL(s) at T1	2.9	2.43	1.9–3.9	3.0	.064	3.9	2.77	2.6–5.1	3.0	.009	5.2	4.24	3.3–7.0	5.0	.003	9.5	5.2	7.5–11.6	9.0	.002
without	2.2	3.25	1.1–3.2	1.0	2.3	3.44	1.2-3.3	1.0	2.1	2.53	1.3–3.0	1.0	5.6	3.9	4.4–6.8	6.0
with	new or deteriorated WSL(s) at T1	3.0	2.49	1.9–4.1	3.0	.104	3.6	2.71	2.3–4.9	3.0	.052	5.2	4.45	3.1–7.4	5.0	.018	9.9	5.5	7.5–12.3	9.0	.003
without	2.2	3.16	1.2–3.1	1.0	2.5	3.48	1.4–3.5	1.0	2.4	2.73	1.5–3.3	1.0	5.8	4.0	4.7–6.9	6.5
MT
with	WSL(s) at T0	0.0	0.00	0.0–0.0	0.0	1.000	0.0	0.00	0.0–0.0	0.0	.593	0.0	0.00	0.0–0.0	0.0	.549	0.4	0.92	-0.3–1.0	0.0	.522
without	0.0	0.00	0.0–0.0	0.0	0.1	0.29	0.0–0.1	0.0	0.1	0.31	0.0–0.2	0.0	0.2	0.65	0.0–0.4	0.0
with	WSL(s) at T1	0.0	0.00	0.0–0.0	0.0	1.000	0.1	0.43	–0.1-0.3	0.0	.610	0.1	0.42	-0.1–0.3	0.0	.714	0.4	1.01	0.0–0.9	0.0	.049
without	0.0	0.00	0.0–0.0	0.0	0.0	0.15	0.0–0.1	0.0	0.0	0.16	0.0–0.1	0.0	0.1	0.36	0.0–0.2	0.0
with	new or deteriorated WSL(s) at T1	0.0	0.00	0.0–0.0	0.0	1.000	0.1	0.46	−0.1–0.3	0.0	.500	0.1	0.46	−0.1–0.3	0.0	.557	0.6	1.10	0.1–1.0	0.0	.011
without	0.0	0.00	0.0–0.0	0.0	0.0	0.15	0.0–0.7	0.0	0.0	0.16	0.0–0.1	0.0	0.1	0.34	0.0–0.2	0.0
FT
with	WSL(s) at T0	3.5	2.72	1.6–5.4	3.5	.085	5.1	3.27	2.4–7.9	4.5	.016	7.1	5.23	3.1–11.1	6.0	.008	10.0	5.60	6.2–13.8	11.0	.034
without	2.3	2.99	1.5–3.1	1.0	2.4	3.17	1.6–3.3	2.0	2.6	2.72	1.8–3.3	1.0	6.3	4.22	5.2–7,4	7.0
with	WSL(s) at T1	2.9	2.43	1.9–3.9	3.0	.064	3.8	2.69	2.6–5.0	3.0	.010	5.1	4.20	3.3–6.9	5.0	.003	9.1	4.95	7.1–11.0	8.0	.003
without	2.2	3.25	1.1–3.2	1.0	2.2	3.46	1.2–3.3	1.0	2.1	2.54	1.2–2.9	1.0	5.5	3.88	4.3–6.7	6.0
with	new or deteriorated WSL(s) at T1	3.0	2.49	1.9–4.1	3.0	.104	3.5	2.61	2.3–4.8	3.0	.054	5.1	4.41	3.0–7.2	5.0	.018	9.4	5.16	7.1–11.7	8.5	.005
without	2.2	3.16	1.2–3.1	1.0	2.4	3.49	1.4–3.5	1.0	2.4	2.75	1.5–3.2	1.0	5.7	3.92	4.6–6.9	6.0

Table 5.

Open in new tab

Data on missing and filled teeth (MFT, MT, FT).

			T0					T1					T2					T3
			M	SD	95% CI	Med	P	M	SD	95% CI	Med	P	M	SD	95% CI	Med	P	M	SD	95% CI	Med	P
Patients	MFT
	with	WSL(s) at T0	3.5	2.72	1.6–5.4	3.5	.085	5.1	3.27	2.4–7.9	4.5	.018	7.1	5.23	3.1–11.1	6.0	.008	10.4	6.1	6.3–14.5	11.0	.043
	without	WSL(s) at T0	2.3	2.99	1.5-3.1	1.0	.085	2.5	3.20	1.6-3.3	2.0	.018	2.6	2.77	1.8-3.4	1.0	.008	6.5	4.4	5.4-7.6	7.0	.043
	with	WSL(s) at T1	2.9	2.43	1.9–3.9	3.0	.064	3.9	2.77	2.6–5.1	3.0	.009	5.2	4.24	3.3–7.0	5.0	.003	9.5	5.2	7.5–11.6	9.0	.002
	without	WSL(s) at T1	2.2	3.25	1.1–3.2	1.0	.064	2.3	3.44	1.2-3.3	1.0	.009	2.1	2.53	1.3–3.0	1.0	.003	5.6	3.9	4.4–6.8	6.0	.002
	with	new or deteriorated WSL(s) at T1	3.0	2.49	1.9–4.1	3.0	.104	3.6	2.71	2.3–4.9	3.0	.052	5.2	4.45	3.1–7.4	5.0	.018	9.9	5.5	7.5–12.3	9.0	.003
	without	new or deteriorated WSL(s) at T1	2.2	3.16	1.2–3.1	1.0	.104	2.5	3.48	1.4–3.5	1.0	.052	2.4	2.73	1.5–3.3	1.0	.018	5.8	4.0	4.7–6.9	6.5	.003
	MT
	with	WSL(s) at T0	0.0	0.00	0.0–0.0	0.0	1.000	0.0	0.00	0.0–0.0	0.0	.593	0.0	0.00	0.0–0.0	0.0	.549	0.4	0.92	-0.3–1.0	0.0	.522
	without	WSL(s) at T0	0.0	0.00	0.0–0.0	0.0	1.000	0.1	0.29	0.0–0.1	0.0	.593	0.1	0.31	0.0–0.2	0.0	.549	0.2	0.65	0.0–0.4	0.0	.522
	with	WSL(s) at T1	0.0	0.00	0.0–0.0	0.0	1.000	0.1	0.43	–0.1-0.3	0.0	.610	0.1	0.42	-0.1–0.3	0.0	.714	0.4	1.01	0.0–0.9	0.0	.049
	without	WSL(s) at T1	0.0	0.00	0.0–0.0	0.0	1.000	0.0	0.15	0.0–0.1	0.0	.610	0.0	0.16	0.0–0.1	0.0	.714	0.1	0.36	0.0–0.2	0.0	.049
	with	new or deteriorated WSL(s) at T1	0.0	0.00	0.0–0.0	0.0	1.000	0.1	0.46	−0.1–0.3	0.0	.500	0.1	0.46	−0.1–0.3	0.0	.557	0.6	1.10	0.1–1.0	0.0	.011
	without	new or deteriorated WSL(s) at T1	0.0	0.00	0.0–0.0	0.0	1.000	0.0	0.15	0.0–0.7	0.0	.500	0.0	0.16	0.0–0.1	0.0	.557	0.1	0.34	0.0–0.2	0.0	.011
	FT
	with	WSL(s) at T0	3.5	2.72	1.6–5.4	3.5	.085	5.1	3.27	2.4–7.9	4.5	.016	7.1	5.23	3.1–11.1	6.0	.008	10.0	5.60	6.2–13.8	11.0	.034
	without	WSL(s) at T0	2.3	2.99	1.5–3.1	1.0	.085	2.4	3.17	1.6–3.3	2.0	.016	2.6	2.72	1.8–3.3	1.0	.008	6.3	4.22	5.2–7,4	7.0	.034
	with	WSL(s) at T1	2.9	2.43	1.9–3.9	3.0	.064	3.8	2.69	2.6–5.0	3.0	.010	5.1	4.20	3.3–6.9	5.0	.003	9.1	4.95	7.1–11.0	8.0	.003
	without	WSL(s) at T1	2.2	3.25	1.1–3.2	1.0	.064	2.2	3.46	1.2–3.3	1.0	.010	2.1	2.54	1.2–2.9	1.0	.003	5.5	3.88	4.3–6.7	6.0	.003
	with	new or deteriorated WSL(s) at T1	3.0	2.49	1.9–4.1	3.0	.104	3.5	2.61	2.3–4.8	3.0	.054	5.1	4.41	3.0–7.2	5.0	.018	9.4	5.16	7.1–11.7	8.5	.005
	without	new or deteriorated WSL(s) at T1	2.2	3.16	1.2–3.1	1.0	.104	2.4	3.49	1.4–3.5	1.0	.054	2.4	2.75	1.5–3.2	1.0	.018	5.7	3.92	4.6–6.9	6.0	.005

			T0					T1					T2					T3
			M	SD	95% CI	Med	P	M	SD	95% CI	Med	P	M	SD	95% CI	Med	P	M	SD	95% CI	Med	P
Patients	MFT
	with	WSL(s) at T0	3.5	2.72	1.6–5.4	3.5	.085	5.1	3.27	2.4–7.9	4.5	.018	7.1	5.23	3.1–11.1	6.0	.008	10.4	6.1	6.3–14.5	11.0	.043
	without	WSL(s) at T0	2.3	2.99	1.5-3.1	1.0	.085	2.5	3.20	1.6-3.3	2.0	.018	2.6	2.77	1.8-3.4	1.0	.008	6.5	4.4	5.4-7.6	7.0	.043
	with	WSL(s) at T1	2.9	2.43	1.9–3.9	3.0	.064	3.9	2.77	2.6–5.1	3.0	.009	5.2	4.24	3.3–7.0	5.0	.003	9.5	5.2	7.5–11.6	9.0	.002
	without	WSL(s) at T1	2.2	3.25	1.1–3.2	1.0	.064	2.3	3.44	1.2-3.3	1.0	.009	2.1	2.53	1.3–3.0	1.0	.003	5.6	3.9	4.4–6.8	6.0	.002
	with	new or deteriorated WSL(s) at T1	3.0	2.49	1.9–4.1	3.0	.104	3.6	2.71	2.3–4.9	3.0	.052	5.2	4.45	3.1–7.4	5.0	.018	9.9	5.5	7.5–12.3	9.0	.003
	without	new or deteriorated WSL(s) at T1	2.2	3.16	1.2–3.1	1.0	.104	2.5	3.48	1.4–3.5	1.0	.052	2.4	2.73	1.5–3.3	1.0	.018	5.8	4.0	4.7–6.9	6.5	.003
	MT
	with	WSL(s) at T0	0.0	0.00	0.0–0.0	0.0	1.000	0.0	0.00	0.0–0.0	0.0	.593	0.0	0.00	0.0–0.0	0.0	.549	0.4	0.92	-0.3–1.0	0.0	.522
	without	WSL(s) at T0	0.0	0.00	0.0–0.0	0.0	1.000	0.1	0.29	0.0–0.1	0.0	.593	0.1	0.31	0.0–0.2	0.0	.549	0.2	0.65	0.0–0.4	0.0	.522
	with	WSL(s) at T1	0.0	0.00	0.0–0.0	0.0	1.000	0.1	0.43	–0.1-0.3	0.0	.610	0.1	0.42	-0.1–0.3	0.0	.714	0.4	1.01	0.0–0.9	0.0	.049
	without	WSL(s) at T1	0.0	0.00	0.0–0.0	0.0	1.000	0.0	0.15	0.0–0.1	0.0	.610	0.0	0.16	0.0–0.1	0.0	.714	0.1	0.36	0.0–0.2	0.0	.049
	with	new or deteriorated WSL(s) at T1	0.0	0.00	0.0–0.0	0.0	1.000	0.1	0.46	−0.1–0.3	0.0	.500	0.1	0.46	−0.1–0.3	0.0	.557	0.6	1.10	0.1–1.0	0.0	.011
	without	new or deteriorated WSL(s) at T1	0.0	0.00	0.0–0.0	0.0	1.000	0.0	0.15	0.0–0.7	0.0	.500	0.0	0.16	0.0–0.1	0.0	.557	0.1	0.34	0.0–0.2	0.0	.011
	FT
	with	WSL(s) at T0	3.5	2.72	1.6–5.4	3.5	.085	5.1	3.27	2.4–7.9	4.5	.016	7.1	5.23	3.1–11.1	6.0	.008	10.0	5.60	6.2–13.8	11.0	.034
	without	WSL(s) at T0	2.3	2.99	1.5–3.1	1.0	.085	2.4	3.17	1.6–3.3	2.0	.016	2.6	2.72	1.8–3.3	1.0	.008	6.3	4.22	5.2–7,4	7.0	.034
	with	WSL(s) at T1	2.9	2.43	1.9–3.9	3.0	.064	3.8	2.69	2.6–5.0	3.0	.010	5.1	4.20	3.3–6.9	5.0	.003	9.1	4.95	7.1–11.0	8.0	.003
	without	WSL(s) at T1	2.2	3.25	1.1–3.2	1.0	.064	2.2	3.46	1.2–3.3	1.0	.010	2.1	2.54	1.2–2.9	1.0	.003	5.5	3.88	4.3–6.7	6.0	.003
	with	new or deteriorated WSL(s) at T1	3.0	2.49	1.9–4.1	3.0	.104	3.5	2.61	2.3–4.8	3.0	.054	5.1	4.41	3.0–7.2	5.0	.018	9.4	5.16	7.1–11.7	8.5	.005
	without	new or deteriorated WSL(s) at T1	2.2	3.16	1.2–3.1	1.0	.104	2.4	3.49	1.4–3.5	1.0	.054	2.4	2.75	1.5–3.2	1.0	.018	5.7	3.92	4.6–6.9	6.0	.005

The mean value (M), standard deviation (SD), 95% confidence interval (CI) and median value are given for T0, T1, T2 and T3. In addition, the P-values for the comparisons affected vs. non-affected at teeth at T0 respectively T1 are displayed.

This Feature Is Available To Subscribers Only